pregnancy model simcyp v21 (Simcyp)
90
Structured Review
Simcyp
pregnancy model simcyp v21
Pregnancy Model Simcyp V21, supplied by Simcyp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pregnancy+model+simcyp+v21/v21/pmc10748010-82-2-4
Average 90 stars, based on 1 article reviews
Pregnancy Model Simcyp V21, supplied by Simcyp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pregnancy+model+simcyp+v21/v21/pmc10748010-82-2-4
Average 90 stars, based on 1 article reviews
pregnancy model simcyp v21 - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
other:Article Title: 2024 Annual Meeting American College of Clinical Pharmacology®. Article Snippet: For alprazolam PBPK model, the Article Title: Application of physiologically based pharmacokinetic modeling of novel drugs approved by the U.S. food and drug administration. Article Snippet: However, the predictive performance of the Leniolisib PBPK model appears to be improved using Article Title: Establishing a physiologically based pharmacokinetic framework for aldehyde oxidase and dual aldehyde oxidase‐CYP substrates Article Snippet: References for Article Title: Evaluation of the Drug–Drug Interaction Potential of Cannabidiol Against UGT2B7-Mediated Morphine Metabolism Using Physiologically Based Pharmacokinetic Modeling Article Snippet: Table S2: Key physiochemical and system specific input parameters for the development of physiologically based pharmacokinetic model for cannabidiol using Article Title: 2024 Annual Meeting American College of Clinical Pharmacology®. Article Snippet: Description of Methods and Materials: Physiologically-based pharmacokinetic models for adult healthy subjects were developed using physicochemical and physiological parameters of atenolol and escitalopram using the Permeability:Article Title: A Bottom-up Approach for Mutant and Wild Type Collies Using Physiologically Based Pharmacokinetic (PBPK) Modeling: A Case Study Using Loperamide. Article Snippet: A bottom-up physiologically based pharmacokinetic (PBPK) model was developed to predict the pharmacokinetics of loperamide, a substrate for multidrug resistance 1 (Mdr1) encoded P-glycoprotein (P-gp), in wild-type dogs (WT) and dogs that are homozygous for a base-pair deletion in the Mdr1 gene encoding for P-gp (Mu, Δ-Mdr1).. In vitro-to-in vivo extrapolation (IVIVE) techniques were employed where in vitro data describing loperamide absorption, distribution, metabolism, and elimination (ADME) were extrapolated to in vivo dose exposure predictions.. Importantly, by applying system parameters extrapolated from other breeds and published information on Collie-specific physiology, for the first time, a breed-specific whole-body PBPK model for the Collie was developed. Analysis:Article Title: Application of physiologically based pharmacokinetic modeling of novel drugs approved by the U.S. food and drug administration. Article Snippet: .. For example, applicant’s PBPK model of Leniolisib (JOENJA, approved for marketing by the FDA on March 24, 2023) used Clinical Proteomics:Article Title: Utility of Physiologically Based Pharmacokinetic Modeling to Investigate the Impact of Physiological Changes of Pregnancy and Cancer on Oncology Drug Pharmacokinetics Article Snippet: .. In the |